Cart
sales@molnova.com
Home - Products - Others - Other Targets - REBAUDIOSIDE B(P)(NEW)

REBAUDIOSIDE B(P)(NEW)

CAS No. 58543-17-2

REBAUDIOSIDE B(P)(NEW)( —— )

Catalog No. M20471 CAS No. 58543-17-2

REBAUDIOSIDE B tastes about 150 times sweeter than sucrose and it is non-caloric.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 86 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    REBAUDIOSIDE B(P)(NEW)
  • Note
    Research use only, not for human use.
  • Brief Description
    REBAUDIOSIDE B tastes about 150 times sweeter than sucrose and it is non-caloric.
  • Description
    REBAUDIOSIDE B tastes about 150 times sweeter than sucrose and it is non-caloric.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    58543-17-2
  • Formula Weight
    804.87
  • Molecular Formula
    C38H60O18
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (124.24 mM)
  • SMILES
    [H][C@@]12CC[C@@]3(C[C@]1(CC3=C)CC[C@]1([H])[C@@](C)(CCC[C@@]21C)C(O)=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.In vitro metabolism of rebaudioside E under anaerobic conditions: Comparison with rebaudioside A[J]. Regulatory Toxicology and Pharmacology 2015 72(3):646-657.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Ipilimumab

    Ipilimumab anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.

  • KT-474

    KT-474 (KYM-001) is a PROTAC degrader targeting interleukin-1 receptor-associated kinase 4 (IRAK4) with antitumor activity for the study of autoimmune, inflammatory, and cardiovascular disease disorders.

  • Amatuximab

    Amatuximab (MORab-009) is a humanized chimeric IgG1/k monoclonal antibody targeting cell surface mesothelin (MSLN) with antitumor activity for the treatment of solid tumors.

Sign In Join Free